Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 95%
filed 2026-07-20
Item 5.02
The filing discloses the appointment of Kevin O'Connor as President of Hanover Bancorp, Inc. and Hanover Community Bank, effective July 27, 2026. While the disclosure includes compensatory details (base salary, incentive compensation eligibility, and a 10,000-share restricted stock award vesting over five years), the principal action and focus of Item 5.02(c) is the appointment itself. The compensation terms are incidental to the appointment announcement and do not constitute a standalone compensatory arrangement disclosure under Item 5.02(e).
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-07-20
Item 2.02
Mesa Royalty Trust issued a press release on July 20, 2026 announcing its royalty income and income distribution for July 2026, specifically that there will be no distribution paid for the month because "costs, charges and expenses attributable to the Trust's royalty properties exceeded the revenue received." This is a periodic financial results disclosure typical of earnings releases under Item 2.02, and the zero-distribution outcome is material to unitholders' assessment of the Trust's cash generation and distribution capacity.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-20
Item 5.02
The company granted RSUs and PSUs to CEO Asim Akram and CFO Robert Nadolny, and amended their RSU Award Agreements and employment agreements to modify change-of-control vesting provisions and establish new equity award treatment in M&A scenarios.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-20
Item 8.01
The filing discloses a declaration of a quarterly cash dividend of $0.35 per share, representing a $0.10 increase from the prior quarterly dividend of $0.25 per share, payable on August 11, 2026. This is a clear dividend distribution event. The increase in dividend is material to investors as it signals improved capital position and management confidence in future earnings, affecting shareholder returns.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-20
Item 1.01
Elutia entered into a definitive Asset Purchase Agreement on July 16, 2026, to sell substantially all assets of its SimpliDerm Business (Women's Health segment) to Cellution Biologics for up to $11 million in cash and milestone payments, completing its strategic process and providing non-dilutive capital to support NXT-41x pipeline development.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-20
Item 8.01
This Item 8.01 filing discloses a material acquisition of WildFire Intermediate Holdings, LLC by Magnolia Oil & Gas Operating LLC (a subsidiary of Magnolia Oil & Gas Corp). The filing incorporates audited and unaudited financial statements of the seller, pro forma combined financial information, and reserve estimates—all standard documentation for a material M&A transaction. The target comprises approximately 810,000 net acres in Texas with proved reserves of 271.2 MMBoe and expected production of 53 MBoe/d, representing a substantial acquisition of oil and gas assets.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-20
Item 2.02
Eagle Nuclear Energy Corp. issued a press release on July 20, 2026, announcing its "financial and operating results for the quarter ended May 31, 2026," which is furnished as Exhibit 99.1. The press release provides a corporate update covering operational milestones, liquidity position ($28.1 million cash, no debt), and strategic progress on the Aurora uranium project and SMR technology platform. This is a standard quarterly earnings/results disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-20
Item 2.03
The company completed a sale-leaseback transaction of 26 company-owned store locations, generating approximately $77 million in net proceeds that will be deployed toward debt reduction. This transaction creates a new direct financial obligation in the form of lease liabilities on the balance sheet.
View raw filing on EDGAR →
8-K
Material Impairment
confidence 95%
filed 2026-07-20
Item 2.06
The company divested Maple Street Biscuit Company (MSBC) assets to Biscuit Belly, LLC and closed 16 remaining MSBC locations, resulting in expected non-cash impairment charges of approximately $37 million to $39 million and additional cash charges of $6 million to $8 million in Q4 fiscal 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-20
Item 5.07
This Item 5.07 disclosure reports the results of Transcode Therapeutics' 2026 Annual Meeting of Stockholders held on July 20, 2026. The filing details voting outcomes on seven proposals, including approval of convertible preferred stock issuances (Proposals 1–2), a Standby Equity Purchase Agreement and convertible notes (Proposal 3), election of six directors (Proposal 4), amendment to the 2021 Stock Option and Incentive Plan (Proposal 5), ratification of the independent auditor (Proposal 6), and adjournment authority (Proposal 7). All proposals were approved. The disclosure is material because shareholder approval of dilutive equity issuances and director elections directly affects investor interests and capital structure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-20
Item 2.02
VOC Energy Trust announced a quarterly distribution of $4,760,000 or $0.28 per unit to unitholders of record on July 30, 2026, payable August 14, 2026. This is a routine but material distribution of cash proceeds from the Trust's net profits interest in oil and gas properties, disclosed via press release under Item 2.02. The distribution amount and per-unit payment are clearly stated, making this a dividend_distribution event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-20
Item 2.02
First United Corporation issued a press release on July 20, 2026 disclosing financial results for the three- and six-month periods ended June 30, 2026, including consolidated net income of $5.7 million ($0.87 per diluted share) for Q2 2026 and $12.3 million ($1.90 per diluted share) for the six-month period, with a net interest margin of 3.98%.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-20
Item 5.02
The Board of Directors appointed Tara Bunch as a director on July 16, 2026. Ms. Bunch brings significant operational and governance experience from senior roles at Airbnb, Apple, and Hewlett-Packard, as well as board service at The Vanguard Group.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-20
Item 1.01
AdaptHealth entered into a definitive asset purchase agreement on July 19, 2026, to divest its Diabetes Health business to Cardinal Health (a subsidiary of RGH Enterprises, LLC) for $235 million in cash. This is a material disposition of a business segment, disclosed under Item 1.01 (Entry Into a Material Definitive Agreement). The transaction is described as "the latest – and most significant – step" in the company's portfolio restructuring and will materially affect the company's revenue, EBITDA margins, and capital structure going forward, with the Diabetes Health segment to be treated as discontinued operations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-20
Item 2.02
SmartFinancial issued a press release on July 20, 2026, reporting Q2 2026 quarterly earnings results with net income of $16.3 million ($0.96 per diluted share), including detailed financial metrics, balance sheet trends, and management commentary. The disclosure was furnished under Item 2.02 with supporting investor presentation materials referenced for the July 21, 2026 earnings conference call.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-20
Item 5.02
William R. Nelson resigned from his position as President of the Republic Processing Group (RPG) effective August 28, 2026, to accept an executive opportunity elsewhere. While the filing also mentions Brent Shuman assuming the interim role, the principal disclosed action is Nelson's departure. The resignation of a division president is material to investors assessing management stability and operational continuity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-07-20
Item 1.01
SmartKem entered into a Securities Purchase Agreement on March 30, 2026, and amended it on July 16, 2026, to sell Series A convertible preferred stock and warrants to institutional investors. The offering raised approximately $17.1 million and includes warrants to purchase approximately 36.7 million shares of common stock, materially diluting existing shareholders upon conversion and exercise.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-20
EX-99.1
This news release announces a material operational milestone at Eldorado Gold's Skouries copper-gold project in Greece: first ore has been crushed through the commissioned crushing circuit, commissioning activities are advancing, and the company targets first concentrate production in Q3 2026 and commercial production in Q4 2026. While this is a significant project development, it does not fit the specific event categories (not an earnings release, M&A activity, impairment, or other named types). The disclosure is clearly operational and strategic—a major construction and development milestone for a material project—making it an operational_other event that would affect a reasonable investor's assessment of the company's progress toward production.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-20
EX-99.1
Osisko Development Corp. changed its corporate name to Osisko Gold Group Inc. and relocated its registered office from Québec to Ontario, effective July 14, 2026, following shareholder approval on June 23, 2026. The name change triggered corresponding ticker symbol changes across TSXV, NYSE, and Nasdaq (ODV to OGG, ODVWZ to OGGWZ), along with new CUSIP and ISIN numbers.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-20
Item 8.01
Oncolytics announced that the FDA granted Fast Track Designation for pelareorep in combination with a checkpoint inhibitor for treating advanced squamous cell carcinoma of the anal canal. This is a significant regulatory milestone that accelerates development and review timelines, represents the third Fast Track designation in gastrointestinal cancers, and addresses an estimated $1 billion market with no approved therapies for second-line patients. While this is a positive regulatory development rather than a traditional operational event, it is a material strategic and regulatory milestone that would affect investor assessment of the company's development trajectory and de-risking of its pipeline.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-20
Item 2.02
This is a clear earnings release disclosing quarterly and six-month financial results for Farmers & Merchants Bancorp. The press release reports record second quarter net income of $24.7 million, diluted EPS of $36.39 (up 10.47% YoY), and detailed financial metrics including net interest income, balance sheet growth, and capital ratios. The filing explicitly states "On July 20, 2026, Farmers & Merchants Bancorp issued a press release concerning financial results for the three-months and six-months ended June 30, 2026" and includes comprehensive financial highlights and management commentary typical of an earnings announcement.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-20
EX-99.1
This press release announces clinical progress in a Phase 2 trial of MP0317 for cholangiocarcinoma, including dosing of first patients, nine activated trial sites, and expected data in 2027. While this is a material operational milestone for a clinical-stage biotech company, it does not fit the specific `earnings_release` category (no financial results disclosed) nor any other named event type. The disclosure is clearly operational—a significant clinical development milestone—making `operational_other` the appropriate classification.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-20
Item 2.02
ServisFirst Bancshares issued a press release on July 20, 2026 announcing second quarter 2026 operating results, disclosing net income of $85.8 million (up 39.7% year-over-year), diluted EPS of $1.57 (up 40% year-over-year), and key metrics including loan growth, deposit growth, and net interest margin expansion.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-20
EX-99.1
Enzo Villani, who was Executive Chairman and Chief Investment Officer, has been appointed to serve as President of Alpha Compute Corp, effective July 16, 2026. This is a material executive appointment expanding his role to include "broader responsibility for corporate strategy, capital allocation, and operational execution." The appointment of a senior executive to a new C-suite position is material to investors assessing company leadership and governance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-20
Item 8.01
ServisFirst's Board declared a two-for-one stock split effected as a 100% stock dividend, with stockholders of record on August 5, 2026 receiving one additional share for each share held on the distribution date of August 20, 2026. This is a return of capital to shareholders in the form of a stock dividend, which falls squarely within the dividend_distribution category. While material to shareholders, the event is a routine capital structure action rather than an earnings release or other operational event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-20
Item 2.02
Monarch Casino & Resort disclosed second quarter 2026 financial results via press release, reporting net revenue of $142.6 million (up 4.2% YoY), net income of $32.5 million (up 20.4% YoY), and diluted EPS of $1.78 (up 23.6% YoY), along with detailed operating metrics.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-20
Item 8.01
The company declared a quarterly cash dividend of $0.30 per share payable on September 15, 2026, to stockholders of record on September 1, 2026, as part of its $1.20 annual dividend program.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-20
Item 2.02
This is a straightforward quarterly earnings release for Q2 2026. The filing discloses consolidated financial results including net income of $7,155,000 ($0.67 per share), net interest income, provision for credit losses, and comprehensive balance sheet and income statement data. The press release titled "Muncy Columbia Financial Corporation Announces Second Quarter 2026 Earnings" is attached as Exhibit 99.1 and incorporated by reference, which is the standard format for earnings disclosures under Item 2.02.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-20
EX-99.1
The exhibit discloses that a Special Committee of the Board is actively evaluating two acquisition proposals: one from a group including Meir Shamir and the CEO, and another from Steel Partners Holdings L.P. to acquire 100% of the Company. This constitutes material M&A activity under Item 1.01 / 2.01 equivalent, as the Committee is formally engaged in reviewing and will make recommendations on potential change-of-control transactions that would materially affect the registrant's structure and shareholder interests.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-20
Item 5.02
The filing discloses the appointment of Liisa Bayko as Chief Financial Officer and Treasurer effective July 20, 2026, along with detailed employment terms including $475,000 base salary, up to 40% annual bonus, and a 220,000-share stock option grant. While the section also mentions Brett Hagen's resignation as Chief Accounting Officer and Amy Vandekop's interim appointment, the primary and most substantive disclosure centers on Bayko's appointment as CFO with comprehensive compensation arrangements. This is a material executive appointment affecting the company's financial leadership.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-20
Item 8.01
Goldman Sachs announced the launch of a proposed public offering of depositary shares representing interests in a new series of Fixed-Rate Reset Non-Cumulative Preferred Stock, Series AA. While technically equity (preferred stock), this instrument creates a direct financial obligation with fixed-rate terms and is economically similar to debt. The company intends to use proceeds to redeem existing Series U Preferred Stock, indicating a refinancing of capital structure. This is material to investors as it affects the company's capital composition and financial obligations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-20
Item 7.01
Galaxy Gaming disclosed that a previously announced merger agreement with Evolution Malta Holding Limited has not closed by the July 17, 2026 outside date due to unsatisfied regulatory conditions, and the company is now evaluating options including seeking an extension or terminating the agreement. This is a material update on the status of a merger transaction that has been pending for two years, directly affecting the registrant's strategic direction and shareholder value.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-07-20
Item 8.01
The disclosure reports positive 2-year efficacy and safety data from the PRISM Phase 2b clinical trial of 4D-150 for wet AMD, including consistent BCVA maintenance, CST control, and significant treatment burden reduction (78–87% fewer injections). This represents a material clinical milestone for a biopharmaceutical company advancing toward Phase 3 trials, affecting investor assessment of the therapeutic candidate's viability and commercial potential. While not a specific named event type, this is clearly an operational/clinical development milestone that would influence a reasonable investor's view of the company's pipeline progress.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-20
Item 7.01
Tempus AI announced entry into a definitive Agreement and Plan of Merger to acquire Personalis, Inc. for $16.25 per share ($1.5 billion enterprise value). The disclosure describes a two-step merger structure with Tempus subsidiaries, subject to shareholder approval and regulatory clearances, with expected closing in late 2026 or early 2027. This is a material acquisition that would substantially affect the registrant's business, assets, and capital structure.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-20
EX-99.1
This exhibit discloses Wipro's audited standalone and consolidated financial results for the quarter ended June 30, 2026, approved by the Board on July 16, 2026. The filing includes complete quarterly income statements, profit/loss figures, EPS data, and auditor's reports with unmodified opinions. This is a discrete earnings announcement, not a periodic report filing itself, and would materially affect investor assessment of the company's quarterly performance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-20
Item 8.01
The filing discloses that Hancock Whitney Corporation has received regulatory approval from the Federal Reserve, FDIC, and Mississippi Department of Banking to complete its previously announced acquisition of OFB Bancshares (parent of One Florida Bank), and that OFB Bancshares shareholders have approved the merger agreement. The acquisition is expected to close on or about August 1, 2026. This is a material acquisition event at an advanced stage (regulatory and shareholder approvals obtained, pending only customary closing conditions).
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-20
Item 2.02
Personalis entered into a definitive Agreement and Plan of Merger with Tempus AI, Inc., whereby Tempus will acquire all outstanding Personalis shares at $16.25 per share, representing a total enterprise value of $1.5 billion, with closing expected in late 2026 or early 2027, subject to shareholder approval and regulatory clearances.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-20
Item 1.01
The Company amended its fee letter with Citibank to increase the Facility Amount from $500 million to $750 million, materially expanding its borrowing capacity and direct financial obligations under the credit facility.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-20
Item 3.03
Damora Therapeutics completed a redomestication from Delaware to the Cayman Islands, effective July 16, 2026, following stockholder approval at a Special Meeting on February 9, 2026. The redomestication involved automatic conversion of all share classes, issuance of a new CUSIP, and amendments to the company's articles of association and bylaws, materially modifying shareholder rights and the company's legal jurisdiction and governance framework.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-20
Item 8.01
The filing discloses an unsolicited acquisition proposal from the company's Chair and CEO, Omid Farokhzad, to acquire all outstanding shares at $2.45 per share plus contingent value rights. Although the Special Committee unanimously rejected the proposal, the receipt and rejection of a material acquisition proposal from a controlling shareholder is a significant M&A-related event that would materially affect a reasonable investor's assessment of the company's prospects and control dynamics.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 80%
filed 2026-07-20
Item 5.02
Nir Naor was appointed as Executive Vice President and Chief Financial Officer effective July 23, 2026, with a compensation package including $480,000 base salary and a 500,000 RSU inducement grant. The appointment reflects the company's focus on strengthening financial oversight with an executive bringing 20+ years of finance and life sciences experience.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-20
Item 1.01
Public Storage completed the issuance of $400 million 4.700% Senior Notes due 2032 and $500 million 5.150% Senior Notes due 2036, totaling $900 million in new direct financial obligations pursuant to supplemental indentures dated July 20, 2026.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-20
Item 7.01
LM Funding America, Inc. changed its corporate name to PowerCompute, Inc. and its ticker symbol from LMFA to PWCM, effective July 22, 2026, with conforming amendments to bylaws. While the company emphasized a strategic business transformation toward high-performance computing and AI infrastructure, the 8-K disclosure itself is a governance/administrative matter affecting corporate identity and trading symbol.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 97%
filed 2026-07-20
Item 2.03
Wabash National completed a private offering of $150 million in aggregate principal amount of 4.00% Convertible Senior Notes due 2032 (including the $20 million overallotment exercised by initial purchasers). The convertible notes are unsecured senior obligations with conversion features allowing holders to convert into up to 11,867,085 shares of common stock at an initial conversion rate of 79.1139 shares per $1,000 principal amount. Net proceeds of approximately $122 million (or $141 million with full option exercise) are intended for general corporate purposes including repayment of existing credit agreement amounts.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-20
Item 8.01
The filing discloses a declaration of a return of capital distribution of $0.62 per share (7.5% of NAV) to shareholders, representing a material capital return. This is a classic dividend_distribution event—a declared distribution to shareholders. The materiality is evident from the substantial magnitude ($3.54 per share returned over four months, representing 43% of December 31, 2025 NAV) and the company's strategic commitment to return 50% or more of NAV by year-end 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-20
Item 1.01
T Series BDC LLC amended and restated its credit facility with Barclays Bank PLC, increasing the facility amount from $600 million to $800 million, representing a material $200 million increase in available borrowing capacity and direct financial obligations.
View raw filing on EDGAR →
8-K
Bankruptcy Filing
confidence 99%
filed 2026-07-20
Item 1.03
Sangamo Therapeutics filed a voluntary petition for Chapter 11 bankruptcy relief on June 23, 2026 (Case No. 26-10989) in the U.S. Bankruptcy Court for the District of Delaware. The company is operating as a debtor-in-possession and has obtained court approval for bidding procedures to sell substantially all assets.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-20
Item 3.01
The Nasdaq Hearings Panel issued a final delisting determination denying Sangamo's request to continue listing on The Nasdaq Capital Market due to failure to meet the minimum bid price requirement. The company's stock has been suspended from Nasdaq and is now trading on the OTCID Basic Market, with Nasdaq expected to file a Form 25 to delist and deregister the common stock.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-20
Item 1.01
Tempus AI entered into an Agreement and Plan of Merger with Personalis, Inc. on July 20, 2026, whereby Tempus will acquire Personalis through a two-step merger structure. The filing discloses detailed merger consideration (stock and cash), closing conditions, representations and warranties, and interim operating covenants—all hallmarks of a material acquisition. This is a classic Item 1.01 disclosure of entry into a material definitive agreement for M&A activity.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-20
Item 2.03
MasTec disclosed the drawdown of $700 million under a new senior unsecured delayed draw term loan agreement and $600 million under an amended credit facility on July 20, 2026, creating direct financial obligations totaling $1.3 billion. The filing explicitly states these borrowings were used to finance the cash consideration for the Superior Group acquisition and related fees and expenses, representing material debt issuance activity under Item 2.03.
View raw filing on EDGAR →